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Introduction
Progressive external ophthalmoplegia (PEO) is one of the most 
common manifestations of mitochondrial disease, either as a 
part of a multisystemic complex disorder or as a predominant 
feature of exclusive mitochondrial myopathy. Many cases of 
PEO are caused by the mutation of mitochondrial DNA (mtD-
NA). A single heteroplasmic deletion of mtDNA is a frequent 
cause of sporadic PEO, being responsible for approximately 
90% and 50% of cases of Kearns-Sayre syndrome and PEO, 
respectively.
1 In other patients who show maternal inheritance 
pattern, PEO is associated with various point mutations of 
mtDNA, of which A3243G is the most frequent.
2 Yet another 
group of PEO patients display autosomal dominant or reces-
sive inheritance patterns that are usually associated with mul-
tiple mtDNA deletions or depletions that arise secondarily to 
nuclear gene defects.
3 The responsible genes include POLG, 
which encodes the catalytic subunit of DNA polymerase γ; SL-
C25A4, which encodes the mitochondrial adenine nucleotide 
translocator ANT1; C10ORF2 (also known as PEO1), which 
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Background and PurposezzProgressive external ophthalmoplegia (PEO) with Mendelian in-
heritance is a heterogeneous group of diseases associated with multiple deletions of mitochondri-
al DNA (mtDNA), which results from the disturbed replication and maintenance of mtDNA sec-
ondary to the mutations of nuclear genes including POLG, SLC25A4, C10ORF2, POLG2, OPA1, 
and RRM2B. The aim of this study was to identify the genetic defects underlying the pathology and 
clinical features in two Korean kindreds with autosomal dominant PEO.
MethodszzTwo pathologically proven PEO patients with a clear autosomal dominant pattern of in-
heritance were selected. To exclude a large-scale rearrangement, a long-range polymerase chain re-
action (PCR) was performed using DNA extracted from biopsied muscle tissue taken from each pa-
tient. All coding regions and exon-intron boundaries of POLG, SLC25A4, C10ORF2, and POLG2 
were amplified by PCR and directly sequenced.
ResultszzOne patient showed multiple deletions of mtDNA on long-range PCR analysis, and two 
known heterozygous missense mutations in SLC25A4 (p.Asp104Gly) and C10ORF2 (p.Glu479Lys) 
were identified in each patient. The p.Asp104Gly mutation in SLC25A4 was identified in the pa-
tient with an early onset, slowly progressive, pure PEO phenotype, while the p.Glu479Lys muta-
tion in C10ORF2 was identified in the other patient, with a late-onset disease and PEO plus pheno-
type.
ConclusionszzTwo mutations affecting nuclear genes were identified in Korean patients with au-
tosomal dominant PEO. Further studies are necessary to identify the clear pathogenetic mechanisms 
and establish genotype-phenotype correlations in autosomal dominant PEO.
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encodes T7 gene-4-like protein with intramitochondrial nucle-
oid localization (TWINKLE), a mitochondrial protein that is 
structurally similar to the phage T7 primase/helicase; POLG2, 
which encodes the p55 accessory subunit of DNA polymerase 
γ; OPA1, which encodes optic atrophy 1; and RRM2B, which 
encodes the small subunit of the ribonucleotide reductase 
p53R2.
4-8
While a few previous studies have documented a single large-
scale mtDNA deletion in patients with PEO and Kearns-Sayre 
syndrome,
9-11 there are no reported cases of PEO associated with 
a nuclear gene mutation in Korea. In this study we analyzed 
two Korean patients with autosomal dominant PEO (ad-PEO) 
to identify the nuclear gene defects that underlie their clinical 
phenotypes and pathology.
Methods
Using our muscle biopsy database, we identified ten patients 
with PEO in whom mitochondrial myopathy was confirmed 
pathologically. Among the patients, two unrelated patients who 
had a family history compatible with ad-PEO were selected for 
the study. For DNA analysis, written informed consent was ob-
tained from the patients, and the study was approved by the 
Pusan National University Hospital Institutional Review Board. 
The DNA was extracted from a biopsied muscle sample from 
each patient and subjected to a long-range polymerase chain 
reaction (PCR) protocol for the amplification of mtDNA, as 
described previously.
12,13 After exclusion of a single large-scale 
rearrangement, PCR amplification of all coding exons and in-
tron-exon boundaries of POLG, SLC25A4, C10ORF2, and 
POLG2 was performed (primer pairs and reaction conditions 
are available on request). Each PCR product was directly se-
quenced using a BigDye terminator cycle sequencing kit (Ap-
plied Biosystems, Foster City, CA, USA) and a 3730×l DNA 
analyzer (Applied Biosystems). The obtained chromatograms 
were compared with the standard DNA sequence of each gene, 
and the aberrant sequences were searched in The Human Gene 
Mutation Database (http://www.hgmd.cf.ac.uk/).
14
Results
DNA analysis
Upon long-PCR amplification of mtDNA, no single large-scale 
mtDNA deletion was observed in either patient, and multiple 
mtDNA deletions were observed in one patient (patient 2). Sub-
sequent sequence analysis revealed heterozygous missense mu-
tations in each patient: c.311A>G (p.Asp104Gly) on exon 2 of 
SLC25A4 in patient 1, and c.1435G>A (p.Glu479Lys) in exon 
2 of C10ORF2 in patient 2 (Fig. 1). No other mutation was 
identified in any other gene investigated.
Fig. 1. Mutations identified in the patients. 
A: Patient 1: a heterozygous point muta-
tion, c.311A>G (p.Asp104Gly), was iden-
tified in exon 2 of SLC25A4. B: Patient 2: 
a heterozygous point mutation, c.1435G 
>A (p.Glu479Lys), was identified in exon 
2 of C10ORF2.
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Clinical features
Patient	1	(SLC25A4	p.Asp104Gly	mutant)
The patient was a 65-year-old female who presented with pro-
gressive bilateral ptosis. The ptosis had begun about 50 years 
previously, at school age, with a subsequent slow progression. 
The patient reported no diplopia, visual disturbance, hearing 
loss, or gait difficulties. She had presented with hypertension 
and a cerebral infarction at the age of 55 years, which had pro-
duced mild right hemiplegia. The patient’s family history was 
significant for the autosomal dominant inheritance pattern of 
PEO; starting from school age, at least 15 members from 4 gen-
erations of her family were affected (Fig. 2A). An examination 
revealed bilateral ptosis, partial limitation of extraocular move-
ment in all directions, and mild facial weakness. The patient 
had normal-sized, round pupils with prompt light reflexes; the 
optic fundi were normal. No other cranial nerve abnormalities-
including hearing loss, dysarthria, dysphagia, neck flexor weak-
ness, and tongue atrophy-were observed. The patient’s individ-
ual limb muscle power was preserved, except for the mild right 
hemiparesis that had developed 10 years previously (at an age 
of 55 years) due to cerebral infarction. The patient’s cognitive, 
sensory and cerebellar functions were normal, and no involun-
tary movement was observed. Deep tendon reflexes were absent 
bilaterally in the biceps, triceps, and ankles, and were reduced 
bilaterally in the knees. A Babinski sign could be evoked on the 
right side. Tests including chest roentgenogram, electrocardio-
gram, complete blood count, liver and renal function test, se-
rum glucose, electrolytes, creatine kinase, lactic acid, pyruvic 
acid, and thyroid function test were all within normal limits. 
Needle electromyography revealed fibrillation potentials, posi-
tive sharp waves, and motor unit potentials with small ampli-
tudes and short durations in all limb muscles tested. Nerve con-
duction evaluation yielded normal findings. A muscle biopsy of 
the left biceps muscle revealed numerous ragged red fibers 
with focal cytochrome oxidase deficiency (Fig. 3A-D).
Patient	2	(C10ORF2	p.Glu479Lys	mutant)
This patient was a 47-year-old male with progressive bilater-
al ptosis, ophthalmoplegia, dysarthria, and dysphagia. The pa-
tient first developed bilateral ptosis, dysarthria, and swallowing 
difficulty at ages of 35, 40, and 44 years, respectively. The pa-
tient also complained of myalgia and paresthesia affecting the 
lower legs 2 years before this visit, and had a significant 10-
year weight loss from 57 to 40 kg. The patient’s family histo-
ry was significant for ad-PEO; his father, an elder sister, and an 
elder brother had progressive ptosis, dysarthria, and dysphagia 
that had begun in childhood (Fig. 2B). A physical examination 
Fig. 2. Family pedigrees of patients 1 
(A) and 2 (B).
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revealed that the patient had a very thin musculature, with a 
weight of 40 kg and a height of 170 cm. Neurological exami-
nation revealed bilateral ptosis, nearly complete ophthalmople-
gia, masseter and temporalis muscle atrophy, facial weakness, 
moderate sensorineural hearing loss with tinnitus, dysarthria 
with nasal voice, dysphagia, and neck flexor weakness; the op-
tic fundi were normal. The patient’s limb muscle power was pre-
served except for a mild elbow flexor weakness, which was 
grade 4 on the Medical Research Council scale. The patient had 
a reduced vibration sensation in the lower extremities, and hy-
poactive deep tendon reflexes in the limbs. No other neurologi-
cal abnormalities were observed. On laboratory examination, 
the patient displayed a mildly elevated serum creatine kinase 
level (342 U/L; normal range, 5-217 U/L). An electrocardiogram 
showed a nonspecific ST-segment elevation in the inferior and 
anterior walls. A chest roentgenogram suggested previous pul-
monary tuberculosis; no evidence of cardiomegaly was observ-
ed. The results of other laboratory tests including serum lactate/
pyruvate, complete blood count, liver and renal functions, elec-
trolytes, blood sugar, and thyroid function were unremarkable. 
A nerve conduction study revealed reduced compound nerve 
action potential amplitudes bilaterally in the sural nerves and 
mildly slow sensory nerve conduction velocities in the median 
and ulnar nerves. Needle electromyography revealed mild neu-
rogenic changes in the limb muscles. The overall electrodiag-
nostic findings were compatible with axonal-type sensorimotor 
peripheral polyneuropathy rather than myopathy. A muscle bi-
opsy performed on the left biceps muscle revealed many ragged 
red fibers with partial deficiencies of cytochrome oxidase ac-
tivities (Fig. 3E-H).
Discussion
The nature of multiple mtDNA deletions in PEO with Men-
delian inheritance has been evaluated previously using single-
muscle-fiber PCR analysis, which showed that each fiber has 
one type of deletion that is different from each cell, suggesting 
that each mtDNA with deletions originates in a mitochondrion 
and expands in postmitotic cells.
15 PEO with multiple mtDNA 
deletions is a genetically heterogeneous entity caused by mu-
tations of nuclear genes that are involved in the replication and 
maintenance of mtDNA. Many ad-PEO families carry a het-
erozygous mutation in one of six genes (POLG, POLG2, SL-
C25A4, C10ORF2, OPA1, or RRM2B), while many autosomal 
recessive PEO families carry POLG mutations. Previous stud-
ies showed that POLG, SLC25A4, and C10ORF2 are three ma-
jor genes that are mutated in ad-PEO, among which POLG is 
the most frequently mutated, with mutations SLC25A4 and 
C10ORF2 being uncommon.
16 OPA1 was not analyzed in our 
study because the OPA1 mutant is always associated with op-
tic atrophy,
17 which was not a feature of our patients. Another 
gene, RRM2B, was not analyzed, since ad-PEO with a RRM2B 
mutation is considered extremely rare, and only two families 
with the same p.R327X mutation have been reported to date.
8
SLC25A4 encodes ANT1, or ADP/ATP translocator, which 
is the most abundant protein in the mitochondrion. ANT is lo-
cated in the inner mitochondrial membrane as a 30-kD homodi-
mer, where it forms a gated pore through which ADP is ex-
changed with ATP. ANT1 is one of the three isoforms of ANT 
that is predominantly expressed in heart and skeletal muscle.
18 
Mutations of ANT1 are associated exclusively with ad-PEO, 
and only six missense mutations have been reported thus far.
14 
The mutation identified in our study (p.Asp104Gly) has been 
Fig. 3. Muscle biopsy findings of patients 1 (A-D) and 2 (E-H) showing multiple cytochrome-C-oxidase-negative ragged red fibers. Samples 
in (A) and (E) are stained with hematoxylin and eosin, those in (B) and (F) are stained with modified Gomori trichrome, those in (C) and (G) 
are stained for succinate dehydrogenase, and those in (D) and (H) are stained for cytochrome (C) oxidase. The white bar indicates 50 μm.Park KP et al.
www.thejcn.com  29
reported previously in a Japanese family with a late-onset pure 
PEO phenotype, and has been well characterized as a patho-
genic mutation.
15 Although the exact mechanism by which 
ANT1 mutations produce multiple mtDNA deletions leading to 
ad-PEO is not yet clearly understood, several mechanisms in-
cluding disturbed intramitochondrial deoxyATP concentration, 
disturbed mitochondrial permeability transition pore opening 
caused by structural defect of ANT1, and increased oxidative 
stress associated with ANT1 dysfunction have been suggested.
4
C10ORF2 encodes TWINKLE; it is a primary mtDNA he-
licase with nucleotide hydrolase activity and is localized to 
mitochondrial nucleoids.
5 TWINKLE interacts functionally 
with the β subunit of polymerase γ,
19 and is stimulated by the 
mitochondrial single-stranded DNA-binding protein
20 to form 
a replication unit of mtDNA.
21 Thus, mutation of C10ORF2 
produces defects in both the maintenance of mtDNA copy num-
ber and the integrity of mtDNA, which leads to multiple dele-
tions of mtDNA and, consequently, disease. Clinically, POLG 
and C10ORF2 mutants share similar phenotypes including 
PEO, myopathy, ataxia, sensory axonal neuropathy, and Par-
kinsonism, and this is probably related to the close functional 
interactions between polymerase γ and TWINKLE.
22 More 
than 29 different mutations have been identified, most of which 
are missense mutations involving exon 1 or 2.
22 The presently 
identified C10ORF2 mutation (p.Glu479Lys) is also located in 
exon 2, and was previously reported as a de novo mutation from 
a young Italian female with early-onset PEO and a stationary 
clinical course.
23 However, our patient showed different clini-
cal features: clear family history of autosomal dominant inher-
itance, onset in the mid-thirties with clinical progression, and 
PEO plus other additional features including dysphagia, dysar-
thria, proximal myopathy, and axonal-type sensorimotor poly-
neuropathy. Although these findings may indicate the phenotyp-
ic heterogeneity of this particular mutation, further accumula-
tion of clinical and genetic data are needed to clarify this issue.
Two known missense mutations have been identified in this 
study in two Korean patients with ad-PEO: one in SLC25A4 
and the other in C10ORF2. The clinical phenotype of the SL-
C25A4 p.Asp104Gly mutant was similar to that described pre-
viously, while the C10ORF2 p.Glu479Lys mutant phenotype 
was quite different. Further molecular biological and clinical 
genetic studies employing larger numbers of patients are need-
ed to establish the clear pathogenetic mechanisms and geno-
type-phenotype correlations in ad-PEO.
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